Phase 1 Multi-cohort Evaluation of [18F]CSB-321 PET Imaging in Participants Receiving Immunotherapy for the Treatment of Cancer
Latest Information Update: 28 Jul 2025
At a glance
- Drugs 18F CSB 321 (Primary)
- Indications Cancer
- Focus Adverse reactions
- Sponsors Cytosite Bio
Most Recent Events
- 28 Jul 2025 New trial record